These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27696685)

  • 1. Structural basis for endotoxin neutralization by the eosinophil cationic protein.
    Pulido D; Garcia-Mayoral MF; Moussaoui M; Velázquez D; Torrent M; Bruix M; Boix E
    FEBS J; 2016 Nov; 283(22):4176-4191. PubMed ID: 27696685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.
    Pulido D; Moussaoui M; Andreu D; Nogués MV; Torrent M; Boix E
    Antimicrob Agents Chemother; 2012 May; 56(5):2378-85. PubMed ID: 22330910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
    Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
    Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
    Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
    Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.
    Torrent M; Pulido D; de la Torre BG; García-Mayoral MF; Nogués MV; Bruix M; Andreu D; Boix E
    J Med Chem; 2011 Jul; 54(14):5237-44. PubMed ID: 21696142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.
    Pulido D; Prats-Ejarque G; Villalba C; Albacar M; Moussaoui M; Andreu D; Volkmer R; Torrent M; Boix E
    Eur J Med Chem; 2018 May; 152():590-599. PubMed ID: 29763807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
    Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
    Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
    Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
    Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock.
    Dankesreiter S; Hoess A; Schneider-Mergener J; Wagner H; Miethke T
    J Immunol; 2000 May; 164(9):4804-11. PubMed ID: 10779788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
    Rosenfeld Y; Lev N; Shai Y
    Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide.
    Japelj B; Pristovsek P; Majerle A; Jerala R
    J Biol Chem; 2005 Apr; 280(17):16955-61. PubMed ID: 15687491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.
    Torrent M; Navarro S; Moussaoui M; Nogués MV; Boix E
    Biochemistry; 2008 Mar; 47(11):3544-55. PubMed ID: 18293932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide bound structures of the active fragments of fowlicidin-1, a cathelicidin family of antimicrobial and antiendotoxic peptide from chicken, determined by transferred nuclear Overhauser effect spectroscopy.
    Bhunia A; Mohanram H; Bhattacharjya S
    Biopolymers; 2009; 92(1):9-22. PubMed ID: 18844294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
    Torrent M; Nogués MV; Boix E
    J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
    Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
    Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect.
    Henning MF; Herlax V; Bakás L
    Innate Immun; 2011 Feb; 17(3):327-37. PubMed ID: 20501516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide.
    Andrä J; Garidel P; Majerle A; Jerala R; Ridge R; Paus E; Novitsky T; Koch MH; Brandenburg K
    Eur J Biochem; 2004 May; 271(10):2037-46. PubMed ID: 15128313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccaride-binding peptides obtained by phage display method.
    Matsumoto M; Horiuchi Y; Yamamoto A; Ochiai M; Niwa M; Takagi T; Omi H; Kobayashi T; Suzuki MM
    J Microbiol Methods; 2010 Jul; 82(1):54-8. PubMed ID: 20412822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.